Zhaoming Lu

508 citations
19 papers · 440 indexed · h-index 12
Topics
PI3K/AKT/mTOR signaling in cancer (8 papers)Cancer-related gene regulation (7 papers)Kruppel-like factors research (5 papers)
Partner nations
ChinaNew Zealand

In The Last Decade

Zhaoming Lu

19 papers receiving 436 citations

Peers

Zhaoming Lu
Comparison fields: 5 of 76
  • Molecular Biology 311
  • Cancer Research 93
  • Oncology 71
  • Pulmonary and Respiratory Medicine 63
  • Epidemiology 45
Replace Peipei Gong with:
Peipei Gong China
Imade Aït-Arsa France
Zhenlian Wang China
Miguel Burgos Spain
Seung Baek Lee South Korea
Hsu-Tung Lee Taiwan
Gang Bao China
Zhaoming Lu relative to Peipei Gong China Peipei Gong's profile →
Citations per field
00.5×1.5×2.0×
Peipei Gong · 1×
Citations per year

Countries citing papers authored by Zhaoming Lu

Since Specialization
Citations

This map shows the geographic impact of Zhaoming Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaoming Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaoming Lu more than expected).

Fields of papers citing papers by Zhaoming Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaoming Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaoming Lu. The network helps show where Zhaoming Lu may publish in the future.

Co-authorship network of co-authors of Zhaoming Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaoming Lu. A scholar is included among the top collaborators of Zhaoming Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaoming Lu. Zhaoming Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 6
2 7
3 23
4 40
5 16
6 6
7 16
8 23
9 29
10 18
11 10
12 1
13 34
14 23
15 11
16 49
17
Notch1 mRNA and protein expression in human esophageal squamous cell carcinoma and normal esophageal tissues
3
18 124
19
[Expression of Notch1 gene in esophageal squamous cell carcinoma cell line EC9706 and its effect on cell apoptosis].
1

About Zhaoming Lu

Zhaoming Lu is a scholar working on Cancer Research, Molecular Biology and Molecular Medicine, having authored 19 papers that have together received 440 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer-related gene regulation (7 papers) and Kruppel-like factors research (5 papers). The work is most often cited by research in Cancer Research (93 citations), Molecular Biology (311 citations) and Neurology (35 citations). Zhaoming Lu has collaborated with scholars based in China and New Zealand. Frequent co-authors include Guiqin Hou, Lexun Xue, Tianli Fan, Fang Tian, Yandan Ren, Wen Zhao, Hongtao Liu, Peirong Xu, Hong‐Min Liu and Dong-Xiao Duan. Their work appears in journals such as Biochemical Pharmacology, Cancer Letters and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026